[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Exousia_Pro](/creator/twitter/Exousia_Pro) "$MAJI - Were thrilled to reconnect with our shareholders and share that while things may have seemed quiet on the surface theres been a lot happening behind the scenes. In the world of biotech periods of silence are often the calm before breakthroughs and weve used this time strategically. By expanding Exousia into new high-potential areas weve been building momentum and positioning the Company for robust futuregrowth. The wait is nearly over. In the coming weeks well unveil a series of exciting developments and opportunities that mark the beginning of an ambitious new chapter. Stay tuned the"  [@Exousia_Pro](/creator/x/Exousia_Pro) on [X](/post/tweet/1943731924754653212) 2025-07-11 17:59:38 UTC XXX followers, 1351 engagements "$MAJI - Dr. Marvin Hausman our Consultant and Chairman of our SAB is developing a white paper on exosome safety. This paper will leverage AIto analyze extensive historical exosome data. The insights gained from this analysis are intended to support futureINDsubmissions to theFDA. Dr. Hausman recently engaged with FDA representatives at the American Society of Clinical Oncology (ASCO) Annual Meeting where the agency expressed interest in integrating AI into future submissions"  [@Exousia_Pro](/creator/x/Exousia_Pro) on [X](/post/tweet/1945897889919828163) 2025-07-17 17:26:24 UTC XXX followers, 1150 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Exousia_Pro
"$MAJI - Were thrilled to reconnect with our shareholders and share that while things may have seemed quiet on the surface theres been a lot happening behind the scenes. In the world of biotech periods of silence are often the calm before breakthroughs and weve used this time strategically. By expanding Exousia into new high-potential areas weve been building momentum and positioning the Company for robust futuregrowth. The wait is nearly over. In the coming weeks well unveil a series of exciting developments and opportunities that mark the beginning of an ambitious new chapter. Stay tuned the"
@Exousia_Pro on X 2025-07-11 17:59:38 UTC XXX followers, 1351 engagements
"$MAJI - Dr. Marvin Hausman our Consultant and Chairman of our SAB is developing a white paper on exosome safety. This paper will leverage AIto analyze extensive historical exosome data. The insights gained from this analysis are intended to support futureINDsubmissions to theFDA. Dr. Hausman recently engaged with FDA representatives at the American Society of Clinical Oncology (ASCO) Annual Meeting where the agency expressed interest in integrating AI into future submissions" @Exousia_Pro on X 2025-07-17 17:26:24 UTC XXX followers, 1150 engagements